Semsarian C, Ingles J, Maron MS, Maron BJ. New perspectives on the prevalence of hypertrophic cardiomyopathy. J Am Coll Cardiol. 2015;65(12):1249–54.

Article  PubMed  Google Scholar 

Ommen SR, Ho CY, Asif IM, Balaji S, Burke MA, Day SM, et al. 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the management of hypertrophic cardiomyopathy: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice guidelines. J Am Coll Cardiol. 2024;83(23):2324–405.

Article  PubMed  Google Scholar 

Maron MS, Olivotto I, Zenovich AG, Link MS, Pandian NG, Kuvin JT, et al. Hypertrophic cardiomyopathy is predominantly a disease of left ventricular outflow tract obstruction. Circulation. 2006;114(21):2232–9.

Article  PubMed  Google Scholar 

Olivotto I, Oreziak A, Barriales-Villa R, Abraham TP, Masri A, Garcia-Pavia P, et al. Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial. Lancet. 2020;396(10253):759–69.

Article  CAS  PubMed  Google Scholar 

Ostrominski JW, Guo R, Elliott PM, Ho CY. Cardiac myosin inhibitors for managing obstructive hypertrophic cardiomyopathy: JACC: heart failure state-of-the-art review. JACC Heart Fail. 2023;11(7):735–48.

Article  PubMed  Google Scholar 

Kirklin JW, Ellis FH. Surgical relief of diffuse subvalvular aortic stenosis. Circulation. 1961;24:739–42. First description of surgical septal myotomy for HOCM.

Article  CAS  PubMed  Google Scholar 

Said SM, Dearani JA, Ommen SR, Schaff HV. Surgical treatment of hypertrophic cardiomyopathy. Expert Rev Cardiovasc Ther. 2013;11(5):617–27.

Article  CAS  PubMed  Google Scholar 

Ommen SR, Maron BJ, Olivotto I, Maron MS, Cecchi F, Betocchi S, et al. Long-term effects of surgical septal myectomy on survival in patients with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2005;46(3):470–6.

Article  PubMed  Google Scholar 

Sorajja P, Fraser R, Steffen R, Harris KM. Alcohol septal ablation for obstructive hypertrophic cardiomyopathy. Interv Cardiol Clin. 2022;11(3):245–55.

PubMed  Google Scholar 

Elhadi M, Guerrero M, Collins JD, Rihal CS, Eleid MF. Safety and outcomes of Alcohol septal ablation prior to transcatheter mitral valve replacement. J Soc Cardiovasc Angiogr Interv. 2022;1(5):100396.

PubMed  PubMed Central  Google Scholar 

Talreja DR, Nishimura RA, Edwards WD, Valeti US, Ommen SR, Tajik AJ, et al. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue. J Am Coll Cardiol. 2004;44(12):2329–32.

Article  PubMed  Google Scholar 

Yokoyama Y, Shimoda T, Shimada YJ, Shimamura J, Akita K, Yasuda R et al. Alcohol septal ablation versus surgical septal myectomy of obstructive hypertrophic cardiomyopathy: systematic review and meta-analysis. Eur J Cardiothorac Surg. 2023;63(3):ezad043.

Mentias A, Smedira NG, Krishnaswamy A, Reed GW, Ospina S, Thamilarasan M, et al. Survival after septal reduction in patients > 65 years old with obstructive hypertrophic cardiomyopathy. J Am Coll Cardiol. 2023;81(2):105–15.

Article  PubMed  Google Scholar 

Lawrenz T, Lawin D, Radke K, Stellbrink C. Acute and chronic effects of endocardial radiofrequency ablation of septal hypertrophy in HOCM. J Cardiovasc Electrophysiol. 2021;32(10):2617–24.

Article  PubMed  Google Scholar 

Zhou M, Ta S, Hahn RT, Hsi DH, Leon MB, Hu R, et al. Percutaneous intramyocardial septal radiofrequency ablation in patients with drug-refractory hypertrophic obstructive cardiomyopathy. JAMA Cardiol. 2022;7(5):529–38.

Article  PubMed  PubMed Central  Google Scholar 

Shuvy M, Postell YY, Carasso S, Marmor D, Strauss BH, Maisano F, et al. Mitral valve interventions for hypertrophic obstructive cardiomyopathy. Can J Cardiol. 2024;40(5):860–8.

Article  PubMed  Google Scholar 

Thomas F, Rader F, Siegel RJ. The Use of MitraClip for symptomatic patients with hypertrophic obstructive cardiomyopathy. Cardiology. 2017;137(1):58–61.

Article  PubMed  Google Scholar 

Carasso S, Marmor DB, Shuvy M. Transcatheter edge to Edge mitral valve repair for mitral regurgitation in hypertrophic cardiomyopathy: a Case Series. Can J Cardiol. 2024;40(2):326–8.

Article  PubMed  Google Scholar 

Greenbaum AB, Ueyama HA, Gleason PT, Khan JM, Bruce CG, Halaby RN, et al. Transcatheter myotomy to reduce left ventricular outflow obstruction. J Am Coll Cardiol. 2024;83(14):1257–72.

Article  PubMed  Google Scholar 

Khan JM, Bruce CG, Greenbaum AB, Babaliaros VC, Jaimes AE, Schenke WH, et al. Transcatheter myotomy to relieve left ventricular outflow tract obstruction: the Septal Scoring along the Midline Endocardium Procedure in animals. Circ Cardiovasc Interv. 2022;15(6):e011686.

Article  PubMed  PubMed Central  Google Scholar